Loading...
01/11 03:09
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a mixed picture: strong financial metrics with a significant preferred equity raise and growth in Lugano, yet vague guidance and lack of clarity in management's responses during the Q&A. The market's reaction may be tempered by uncertainties in growth forecasts and unclear strategies, despite positive signals like deleveraging efforts and potential sales boosts from brand refreshes. Given the company's market cap and the mixed signals, a neutral stock price movement is likely in the short term.
Consolidated Net Sales Q4 2024 $620.3 million, up 13.8% year-over-year. Growth driven by consumer businesses, including Lugano, BOA, PrimaLoft, and Honey Pot, all delivering double-digit growth.
Adjusted EBITDA Q4 2024 $118 million, up 29% year-over-year. Growth primarily driven by strong operational performance across subsidiaries, despite a one-time charge of $11.8 million related to inventory write-down at 5.11.
Adjusted Earnings Q4 2024 $46.6 million, up 34% year-over-year. Reflects strong performance across subsidiaries.
Pro Forma Revenue Growth Consumer Vertical 2024 Double-digit growth, with pro forma adjusted EBITDA increasing by greater than 27% year-over-year, despite a $12 million write-down at 5.11 due to PFAS regulations.
Lugano Adjusted EBITDA 2024 $195 million, up 76.4% year-over-year. Driven by a disruptive business model in the luxury collectibles market.
Cash Flow from Operations Q4 2024 $9 million, with other businesses generating greater than $25 million, excluding Lugano.
Total Leverage Ratio Q4 2024 3.58x, which includes over $20 million of one-time costs. Excluding these costs, the leverage ratio would be closer to 3.4x.
Capital Expenditures Q4 2024 $22.9 million, an increase of $6 million over the prior year, primarily related to a plant relocation at Arnold.
Preferred Equity Raised 2024 More than $115 million, aimed at deleveraging the balance sheet and reducing overall weighted average cost of capital.
New Product Introduction: In 2024, CODI acquired the Honey Pot, a purpose-driven business focused on disrupting the feminine hygiene market with plant-derived solutions. 5.11 is expected to focus on growth from new product introductions and continued penetration in the direct-to-consumer segment.
Market Expansion: Altor subsidiary acquired Lifoam, a leading manufacturer of temperature-controlled packaging products, expanding CODI's presence in the cold chain sector. Lugano plans to open one new salon in the first half of 2025 and two more in the second half, indicating market expansion.
Operational Efficiency: CODI raised over $115 million in preferred equity to improve capital structure and reduce overall weighted average cost of capital. The integration of Lifoam is expected to drive meaningful synergies over the next several quarters.
Strategic Shift: CODI divested its Ergobaby subsidiary and streamlined its Velocity Outdoor business to optimize long-term focus. Revised management services agreement to align management compensation with shareholder interests and reduce long-term costs.
Geopolitical Risks: Geopolitical uncertainty driven by tariffs and the potential for a trade war creates incremental risk for 2025. The company is monitoring the situation closely but believes its subsidiaries have taken steps to diversify supply chains and limit risk.
Supply Chain Challenges: Disruption in the global supply chain and labor disruptions are highlighted as significant risks. The company has proactively taken steps to geographically diversify sourcing operations to strengthen global supply chains.
Economic Factors: The domestic and global political and economic environment, including inflation and changing interest rates, may significantly impact the company and its subsidiaries.
Regulatory Issues: The company faced a $12 million write-down of inventory at 5.11 related to PFAS regulations, which impacted adjusted EBITDA.
Integration Challenges: Difficulties in integrating acquired businesses pose a risk, although the company believes it is managing these challenges effectively.
Acquisitions: In 2024, CODI acquired The Honey Pot, a business focused on disrupting the feminine hygiene market, and Lifoam, a manufacturer of temperature-controlled packaging products.
Divestitures: CODI divested its Ergobaby subsidiary and the Crosman airgun business to optimize long-term focus.
Capital Structure Improvement: Raised over $115 million in preferred equity to deleverage the balance sheet and reduce overall cost of capital.
Share Buyback: Bought back over 400,000 shares of CODI common stock in Q4 2024.
Management Fee Structure: Revised management services agreement to reduce long-term costs and align management compensation with shareholder interests.
Centers of Excellence: Established centers focusing on internal audit, sustainability, AI, and business automation to drive value.
2025 Adjusted EBITDA Guidance: Expected to be between $570 million and $610 million.
2025 Consumer Vertical Adjusted EBITDA Guidance: Expected to be between $440 million and $465 million.
2025 Industrial Vertical Adjusted EBITDA Guidance: Expected to be between $130 million and $145 million.
2025 Consolidated Adjusted Earnings Guidance: Expected to be between $170 million and $190 million.
2025 CapEx Guidance: Expected to be between $80 million and $90 million.
Share Buyback Program: In the fourth quarter, CODI bought back more than 400,000 shares of common stock, motivated by the significant discount between the share price and the perceived intrinsic value.
The earnings call summary presents a mixed picture: strong financial metrics with a significant preferred equity raise and growth in Lugano, yet vague guidance and lack of clarity in management's responses during the Q&A. The market's reaction may be tempered by uncertainties in growth forecasts and unclear strategies, despite positive signals like deleveraging efforts and potential sales boosts from brand refreshes. Given the company's market cap and the mixed signals, a neutral stock price movement is likely in the short term.
The earnings call highlighted strong financial performance with significant revenue and EBITDA growth, along with a new $100 million share repurchase program. Despite supply chain and labor challenges, the optimistic guidance and strategic focus on M&A, along with increased consumer vertical EBITDA guidance, present a positive outlook. The market cap suggests moderate sensitivity to these factors, leading to a predicted positive stock movement of 2% to 8%.
CODI's earnings call shows strong financial performance with a 27% rise in adjusted EBITDA and increased guidance, offsetting the loss from Crosman's sale. The company's strategic focus on growth and successful acquisition of HoneyPot, along with strong performances in Lugano and BOA, bolster confidence. Despite some concerns in the industrial segment, the consumer segment's growth is robust. The Q&A reveals optimism about M&A opportunities and leverage management. Considering CODI's market cap, these factors suggest a positive stock price movement over the next two weeks.
The earnings call summary shows strong financial metrics with an 8% revenue increase and a 28% rise in adjusted EBITDA. Positive guidance and strategic growth plans, including international expansion and innovation, are highlighted. The Q&A section reinforces optimism, with expectations of continued growth and successful inventory management. Despite some vague responses, the overall sentiment is positive. With a market cap of $1.64 billion, the stock is likely to experience a positive reaction, potentially in the range of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
